In the wake of GlaxoSmithKline’s announcement that the London-based company will pay the U.S. government $3 billion to settle civil and criminal charges over the illegal marketing of Avandia, U.S. District Judge Cynthia Rufe is now pushing for the resolution of all remaining patient lawsuits over the medication.
To that end, Judge Rufe this week appointed a mediator to handle the settlement negotiations for an undisclosed number of Avandia cases, which were consolidated before her in Philadelphia. According to court filings, Rufe has also set a 75-day deadline for the resolution of at least 85 percent of the remaining cases. Should the court-appointed mediator be unable to facilitate the resolution of these cases within the time allotted, Rufe also announced that she will put 100 of the oldest cases into a trial pool and push for their presentation to jurors within 60 days.
Glaxo has already shelled-out more than $700 million to resolve approximately 10,000 cases of patient claims that Avandia caused adverse events such as heart attack and stroke. It is estimated that the pharmaceutical company still faces more than 20,000 cases involving the drug.
Fill out our contact form below for your free, no obligation case review.
Contact Our Orlando Attorney
If you have been injured in an accident, turn to Frank M. Eidson P.A. Whether your case is a simple collision or a complicated auto wrongful death case, contact personal injury lawyer Frank Eidson today to schedule your free consultation.